Please use this identifier to cite or link to this item: http://repository.ipb.ac.id/handle/123456789/76233
Title: Anti-acne and Tyrosinase Inhibition Properties of Taxifolin and Some Flavanonol Rhamnosides from Kempas (Koompassia malaccensis)
Authors: Batubara, Irmanida
Kuspradini, Harlinda
Mitsunaga, Tohru
Issue Date: 2010
Publisher: Wood Reswearch Jornal
Series/Report no.: Vol.1 •;No. 1
Abstract: Taxifolin (1) and some flavanonol rhamnosides (neoastilbin (2), astilbin (3), and isoastilbin (4)) have been isolated from kempas (Koompassia malaccensis). Our previous research about antimicrobial activity against Streptococcus sobrinus and glucosyltransferase inhibitory activity of these compounds have been reported. Now, we carried out the antiacne and tyrosinase inhibition properties of all four compounds. Antimicrobial against Propionibacterium acnes, P. acnes lipase inhibitory activity and antioxidant activity were established for anti-acne activity. Tyrosinase inhibition property was measured using L-tyrosine and L-DOPA as substrate. The results for anti-acne showed that no antimicrobial activity against P. acnes for all compounds, the best lipase inhibition properties showed on compound 4 with IC50 about 1.36 g/ml, and % inhibition for antioxidant at concentration 10 g/ml are 31.16, 25.64, 28.47, and 31.01% respectively. Tyrosinase inhibition of compound 1 at concentration 1 mg/ml is 24.12% for monophenolase and 5.18% for diphenolase. Compound 2 has tyrosinase inhibition about 25.95% (monophenolase) and 14.18% (diphenolase) at concentration 1 mg/ml. Compound 3 has tyrosinase inhibition about 27.17% (monophenolase) and 6.23% (diphenolase) at same concentration, while compound 4 has tyrosinase inhibition about 11.17% (monophenolase) and 9.75% (diphenolase).
URI: http://repository.ipb.ac.id/handle/123456789/76233
ISSN: 2087~3840
Appears in Collections:Faculty of Mathematics and Natural Sciences

Files in This Item:
File SizeFormat 
ART2010iba.pdf165.22 kBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.